Cellular therapy for type 1 diabetes: Has the time come?

JAMA

Volumn 297, Issue 14, 2007, Pages 1599-1600

  Skyler, Jay S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EDITORIAL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; AUTOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; NOTE;

DIABETES MELLITUS, TYPE 1; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; TRANSPLANTATION, AUTOLOGOUS;

EID: 34247153099     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.14.1599     Document Type: Editorial

References (39)

1. Atkinson MA, Eisenbarth G. Type 1 diabetes. Lancet. 2001;358:221-229.
2. Atkinson MA. Thirty years of investigating the autoimmune basis for type 1 diabetes. Diabetes. 2005;54:1253-1263.
3. Skyler JS, Marks JB. Immune intervention in type 1 diabetes mellitus. Diabetes Reviews. 1993;1:15-42.
4. Skyler JS. Immunotherapy for interdicting the type 1 diabetes disease process. In: Pickup J, Williams G, eds. Textbook of Diabetes. 3rd ed. Oxford, England: Blackwell Publishing Ltd; 2003:74.1-74.12.
5. Herold KC, Hagopian W, Auger JA, et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med. 2002;346:1692-1698.
6. Keymeulen B, Vandemeulebroucke E, Ziegler AG, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med. 2005;352:2598-2608.
7. Diabetes Prevention Trial-Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus N Engl J Med. 2002;346:1685-1691.
8. European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. European Nicotinamide Diabetes Intervention Trial (ENDIT). Lancet. 2004;363:925-931.
9. Diabetes Prevention Trial-Type 1 Study Group. Effects of oral insulin in relatives of patients with type 1 diabetes mellitus. Diabetes Care. 2005;28:1068-1076.
10. Type 1 Diabetes TrialNet Web Site. http://www.diabetestrialnet.org. Accessibility verified March 15, 2007.
11. Voltarelli JC, Couri CEB, Stracieri ABPL, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA. 2007;297:1568-1576.
12. Ikehara S, Ohtsuki H, Good RA, et al. Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci U S A. 1985;82:7743-7747.
13. Mathieu C, Casteels K, Bouillon R, Waer M. Protection against autoimmune diabetes in mixed bone marrow chimeras. J Immunol. 1997;158:1453-1457.
14. Lampeter EF, Homberg M, Quabeck K, et al. Transfer of type 1 diabetes between HLA-identical siblings by bone marrow transplantation. Lancet. 1993;341: 1243-1244.
15. Lampeter EF, McCann SR, Kolb H. Transfer of diabetes type 1 by bone-marrow transplantation. Lancet. 1998;351:568-569.
16. Nelson JL, Torrez R, Louie FM, et al. Pre-existing autoimmune disease in patients with longterm survival after allogeneic bone marrow transplantation. J Rheumatol Suppl. 1997;48:23-29.
17. Leiter EH, Serreze DV. Autoimmune diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol. 1991;59:323-334.
18. Sorli CH, Greiner DL, Mordes JP, Rossini AA. Stem cell transplantation for treatment of autoimmune diseases. Graft. 1998;1:71-81.
19. Burt RK, Slavin S, Burns WH, Marmont AM. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation. Blood. 2002;99:768-784.
20. Burt RK, Verda L, Oyama Y, et al. Non-myeloablative stem cell transplantation for autoimmune diseases. Springer Semin Immun. 2004;26:57-69.
21. Domenick MA, Ildstad ST. Impact of bone marrow transplantation on type I diabetes. World J Surg. 2001;25:474-480.
22. Burt RK, Oyama Y, Traynor A, Kenyon NS. Hematopoietic stem cell therapy for type 1 diabetes. Autoimmun Rev. 2002;1:133-138.
23. Burt RK, Oyama Y, Traynor A, et al. Hematopoietic stem cell transplantation for systemic sclerosis with rapid improvement in skin scores. Bone Marrow Transplant. 2003;32(suppl 1):S65-S67.
24. Snowden JA, Passweg J, Moore JJ, et al. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis. J Rheumatol. 2004;31:482-488.
25. Oyama Y, Craig RM, Traynor AE, et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology. 2005; 128:552-563.
26. Burt RK, Traynor A, Statkute L, et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA. 2006;295:527-535.
27. Burt RK, Marmont A, Oyama Y, et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases. Arthritis Rheum. 2006;54:3750-3760.
28. Illei GG. Hematopoietic stem cell transplantation in autoimmune diseases. Arthritis Rheum. 2006;54:3730-3734.
29. Gale EA. Latent autoimmune diabetes in adults. Diabetologia. 2005;48:2195-2199.
30. Pasquali L, Fan Y, Trucco M, Ringquist S. Rehabilitation of adaptive immunity and regeneration of beta cells. Trends Biotechnol. 2006;24:516-522.
31. Martin S, Pawlowski B, Greulich B, et al. Natural course of remission in IDDM during 1st year after diagnosis. Diabetes Care. 1992;15:66-74.
32. Lo J, Clare-Salzler MJ. Dendritic cell subsets and type I diabetes. Autoimmun Rev. 2006;5:419-423.
33. Perone MJ, Bertera S, Tawadrous ZS, et al. Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice. J Immunol. 2006;177: 5278-5289.
34. Tang Q, Bluestone JA. Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev. 2006;212:217-237.
35. Ende N, Chen R, Reddi AS. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun. 2004; 325:665-669.
36. Santana A, Ensenat-Waser R, Arribas MI, et al. Insulin-producing cells derived from stem cells. J Cell Mol Med. 2006;10:866-883.
37. Tuch BE. Stem cells-a clinical update. Aust Fam Physician. 2006;35:719-721.
38. Hampton T. Stem cells probed as diabetes treatment. JAMA. 2006;296:2785-2786.
39. Elkin G, Prigozhina TB, Slavin S. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation. Exp Hematol. 2004;32:579-584.